Laurel H. Messer, United States of America

Barbara Davis Center for Diabetes Barbara Davis Center for Diabetes
Laurel Messer (Ph.D., RN, CDCES) is an Assistant Professor of Pediatrics at the Barbara Davis Center for Diabetes, University of Colorado School of Medicine. She is a clinical scientist who has specialized in the care of children, adolescents, and young adults with Type 1 Diabetes for 17 years. She is founder of the PANTHER Program (Practical AdvaNced THERapies for Diabetes), dedicated to creating resources for persons with diabetes and healthcare professionals related to diabetes technology (http://BDCPantherDiabetes.org ). She is also a research investigator, conducting numerous clinical research studies related to insulin pumps, continuous glucose monitors (CGM), and automated insulin delivery/closed-loop systems. Dr. Messer’s research interests include factors related to uptake and ongoing use of diabetes technology including CGM, insulin pump, and artificial pancreas systems for individuals with diabetes. She lectures and teaches about Type 1 diabetes and diabetes technology at universities, hospitals, and national and international conferences, and has published over 50 peer- reviewed manuscripts related to implementation of diabetes technology.

Presenter of 4 Presentations

 Conference Calendar
PLENARY SESSION

Practical Implementation of Diabetes Technology

Date
Fri, 04.06.2021
Session Name
0320 - Plenary Session 02: ATTD Yearbook 2020 (ID 35)
Lecture Time
15:13 - 15:19
Presenter
Authors
INDUSTRY SESSION

Introduction

Date
Thu, 03.06.2021
Session Name
0180 - Plenary Industry Symposium 06 (Not Included In The Main Event CME/CPD Credit) (ID 21)
Lecture Time
15:40 - 15:45
Presenter
Authors
INDUSTRY SESSION

Updates with the Dexcom G7 Technology

Date
Thu, 03.06.2021
Session Name
0180 - Plenary Industry Symposium 06 (Not Included In The Main Event CME/CPD Credit) (ID 21)
Lecture Time
17:00 - 17:10
Presenter
Authors
PARALLEL SESSION

Automated Insulin Delivery—Best practices for onboarding and follow-up

Date
Wed, 02.06.2021
Session Name
0130 - Live Q&A: Parallel Session 02: Closed-Loop (ID 15)
Lecture Time
20:32 - 20:52
Presenter
Authors

Abstract

Abstract Body

An increasing number of Automated Insulin Delivery (AID) devices are available for commercial use for persons with diabetes. Typically, industry trainers are responsible for onboarding users to the new technology, and there is no universal clinical follow-up in the first few months of use. Ideal onboarding to AID systems should include a) thorough pre-AID education on general diabetes self-management, carbohydrate counting, insulin pump and continuous glucose monitoring basics, and expectations for AID systems b) Actual device training via face-to-face or teleconference based training, and c) clinical follow-up with diabetes professionals in the first 2-6 weeks of use for device optimization, troubleshooting, and reinforcing expectations . Clinical centers should consider ways to implement pre-AID education and post-AID clinical follow up for new AID device users to mitigate the risk of potential device discontinuation or unsafe practices.

Hide

Moderator of 1 Session

 Conference Calendar
INDUSTRY SESSION

Plenary Industry Symposium 06 (Not Included In The Main Event CME/CPD Credit)

Date
Thu, 03.06.2021
Session Type
INDUSTRY SESSION
Session Time
15:40 - 17:10
Room
Hall A
Chair(s)
Session Description

Dexcom CGM:  Technology Updates and The Broad Ecosystem of Partner AID Systems - Industry Symposium Supported by Dexcom